首页 | 本学科首页   官方微博 | 高级检索  
     


Pharmacophore modelling,molecular docking and virtual screening for EGFR (HER 1) tyrosine kinase inhibitors
Authors:A.K. Gupta  S.S. Bhunia  V.M. Balaramnavar
Affiliation:Medicinal and Process Chemistry Division, Central Drug Research Institute, CSIR , Lucknow, India
Abstract:A pharmacophore model has been developed using diverse classes of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitors useful in the treatment of human tumours. Among the top 10 generated hypotheses, the second hypothesis, with one hydrogen bond acceptor, one ring aromatic and three hydrophobic features, was found to be the best on the basis of Cat Scramble validation as well as test set prediction (r training?=?0.89, r test?=?0.82). The model also maps well to the external test set molecules as well as clinically active molecules and corroborates the docking studies. Finally, 10 hits were identified as potential leads after virtual screening of ZINC database for EGFR TK inhibition. The study may facilitate the designing and discovery of novel EGFR TK inhibitors.
Keywords:EGFR tyrosine kinase  HER 1  Discovery Studio  pharmacophore  docking  virtual screening
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号